Judge Says Apotex Generic Doesn't Infringe Cephalon Patent
A Pennsylvania federal judge on Wednesday said an abbreviated new drug application by Apotex, Inc. does not infringe Cephalon Inc.'s patent for its narcolepsy drug Provigil, finding Apotex's method for producing...To view the full article, register now.
Already a subscriber? Click here to view full article